ALEJANDRO
ESPI MACIAS
TITULAR DE UNIVERSIDAD
![Foto de ALEJANDRO](/img/nophoto.png)
![Foto de Hospital Vall d'Hebron](/img/noimage_org.png)
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (9)
2024
2021
-
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 1, pp. 29-42
-
Trends and outcome of neoadjuvant treatment for rectal cancer: A retrospective analysis and critical assessment of a 10-year prospective national registry on behalf of the Spanish Rectal Cancer Project
European Journal of Surgical Oncology, Vol. 47, Núm. 2, pp. 276-284
2020
2018
-
Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO
Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227
2017
-
Impact of resection versus no resection of the primary tumor on survival in patients with colorectal cancer and synchronous unresectable metastases: protocol for a randomized multicenter study (CR4)
International Journal of Colorectal Disease, Vol. 32, Núm. 7, pp. 1085-1090
-
Individual surgeon is an independent risk factor for leak after double-stapled colorectal anastomosis: An institutional analysis of 800 patients
Surgery (United States), Vol. 162, Núm. 5, pp. 1006-1016
2015
-
Oncological outcome following anastomotic leak in rectal surgery
British Journal of Surgery, Vol. 102, Núm. 4
2013
-
Resultados del proyecto docente y auditado del cáncer de recto de la Asociación Española de Cirujanos. Seis años desde su inicio
Cirugia Espanola, Vol. 91, Núm. 8, pp. 496-503